Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Johnston, , Katy,
DOB: 19-SEP-1988 (Age: 37)
Gender: female
Address:
Flat 16f
Stokes roads
E1 London (United Kingdom)
ID: 1854-452946-6 (ECI)
Report
Date: 11-MAR-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 11-MAR-2018

Chemistry

Test 11-MAR-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 203.8 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 119.0 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 123.2 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.8 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated total cholesterol, while LDL, HDL, and triglycerides are within normal limits. This lipid profile suggests a slightly increased cardiovascular risk, but no significant dyslipidemia. Recommend lifestyle modifications and periodic monitoring. No acute laboratory concerns.